Market Tracker

10/31 7:05pm ET

Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

During the Trading Day
143.85 -0.65 / -0.45%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
143.87 +0.0173 / +0.01%
 
Volume: 7.7K

Today’s Trading

Previous close144.50
Today’s open147.14
Day’s range143.56 - 147.51
Volume1,286,418
Average volume (3 months)1,874,388
Market cap$9.2B
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+115.84%
Earnings growth (this year)+64.14%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+26.98%
P/E ratio171.3
Price/Sales5.95
Price/Book12.28

Competitors

 Today’s
change
Today’s
% change
HSPHospira Inc-0.54-1.00%
RDYDr.Reddy's Laborator...+1.36+2.67%
PCYCPharmacyclics Inc-3.93-2.92%
ENDPEndo International P...+0.63+0.95%
Data as of 4:04pm ET, 10/31/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)$1.55
Annual revenue (last year)$933.8M
Annual profit (last year)$143.0M
Net profit margin15.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Carolyn J. Logan
CFO, Executive VP-Finance &
Administration
Adam C. Derbyshire
Corporate headquarters
Raleigh, North Carolina

Forecasts